These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19608733)

  • 1. Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.
    Miyaki A; Yang P; Tai HH; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G559-66. PubMed ID: 19608733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
    Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UV radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression.
    Judson BL; Miyaki A; Kekatpure VD; Du B; Gilleaudeau P; Sullivan-Whalen M; Mohebati A; Nair S; Boyle JO; Granstein RD; Subbaramaiah K; Krueger JG; Dannenberg AJ
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1104-11. PubMed ID: 20643784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1.
    Subbaramaiah K; Howe LR; Zhou XK; Yang P; Hudis CA; Kopelovich L; Dannenberg AJ
    Cancer Prev Res (Phila); 2012 Oct; 5(10):1183-94. PubMed ID: 22787115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors.
    Pham H; Chen M; Li A; King J; Angst E; Dawson DW; Park J; Reber HA; Hines OJ; Eibl G
    Pancreas; 2010 Apr; 39(3):332-9. PubMed ID: 19820419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.
    Kaliberova LN; Kusmartsev SA; Krendelchtchikova V; Stockard CR; Grizzle WE; Buchsbaum DJ; Kaliberov SA
    Mol Cancer Ther; 2009 Nov; 8(11):3130-9. PubMed ID: 19887544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells.
    Kim HR; Lee HN; Lim K; Surh YJ; Na HK
    Mutat Res; 2014 Oct; 768():6-15. PubMed ID: 25773924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.
    Mann JR; Backlund MG; Buchanan FG; Daikoku T; Holla VR; Rosenberg DW; Dey SK; DuBois RN
    Cancer Res; 2006 Jul; 66(13):6649-56. PubMed ID: 16818638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
    Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C
    Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells.
    Mehdawi LM; Satapathy SR; Gustafsson A; Lundholm K; Alvarado-Kristensson M; Sjölander A
    Oncotarget; 2017 May; 8(21):35033-35047. PubMed ID: 28402256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
    Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone.
    Greenland KJ; Jantke I; Jenatschke S; Bracken KE; Vinson C; Gellersen B
    Endocrinology; 2000 Feb; 141(2):581-97. PubMed ID: 10650939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer.
    Backlund MG; Mann JR; Holla VR; Shi Q; Daikoku T; Dey SK; DuBois RN
    Cancer Res; 2008 Nov; 68(22):9331-7. PubMed ID: 19010907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic structure and transcriptional regulation of the human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene.
    Nandy A; Jenatschke S; Hartung B; Milde-Langosch K; Bamberger AM; Gellersen B
    J Mol Endocrinol; 2003 Aug; 31(1):105-21. PubMed ID: 12914529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer.
    Yang L; Amann JM; Kikuchi T; Porta R; Guix M; Gonzalez A; Park KH; Billheimer D; Arteaga CL; Tai HH; DuBois R; Carbone DP; Johnson DH
    Cancer Res; 2007 Jun; 67(12):5587-93. PubMed ID: 17575121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.
    Lu D; Han C; Wu T
    J Biol Chem; 2013 Jul; 288(27):19484-502. PubMed ID: 23687300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
    Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A
    Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells.
    Smartt HJ; Greenhough A; Ordóñez-Morán P; Talero E; Cherry CA; Wallam CA; Parry L; Al Kharusi M; Roberts HR; Mariadason JM; Clarke AR; Huelsken J; Williams AC; Paraskeva C
    Gut; 2012 Sep; 61(9):1306-14. PubMed ID: 22082586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells.
    Chi X; Freeman BM; Tong M; Zhao Y; Tai HH
    Arch Biochem Biophys; 2009 Jul; 487(2):139-45. PubMed ID: 19501039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite effect of phorbol ester PMA on PTGS2 and PGDH mRNA expression in human chorion trophoblast cells.
    Casciani V; Marinoni E; Bocking AD; Moscarini M; Di Iorio R; Challis JR
    Reprod Sci; 2008 Jan; 15(1):40-50. PubMed ID: 18212353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.